Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study

Ganapathi, M., Campbell, P., Ofori, K., Aggarwal, V., Francis, R. O., & Kratz, A. (2022). Impact of pre‐emptive rapid testing for glucose‐6‐phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study. British Journal of Clinical Pharmacology, 88(9), 4163–4170. Portico. https://doi.org/10.1111/bcp.15353
Authors:
Mythily Ganapathi
Peter Campbell
Kenneth Ofori
Vimla Aggarwal
Richard O Francis
Alexander Kratz
Affiliated Authors:
Mythily Ganapathi
Peter Campbell
Kenneth Ofori
Vimla Aggarwal
Richard O Francis
Alexander Kratz
Columbia Affiliation:
Subjects:
Management and Treatment of Tumor Lysis Syndrome (OpenAlex Topic)
Management of Hyperbilirubinemia in Newborn Infants (OpenAlex Topic)
Nephropathic Cystinosis Research (OpenAlex Topic)
Glucosephosphate Dehydrogenase Deficiency (MeSH)
Urate Oxidase (MeSH)
Author Keywords:
adverse reaction
glucose-6-phosphate dehydrogenase
haemolysis
methemoglobinaemia
pharmacogenomics
rapid testing
rasburicase
tumour lysis syndrome
uric acid
elink
Publication Type:
Article
Unique ID:
10.1111/bcp.15353
PMID:
35419830
DOI:
10.1111/bcp.15353
Journal:
British Journal of Clinical Pharmacology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record
View OpenAlex Record

Record Created: